Want to see TSE:ASTI full AI Analyst Report?
Aquarius Surgical Technologies (ASTI) AI Stock Analysis
Aquarius Surgical Technologies
(CNQX:ASTI)
The score is held down primarily by weak financial performance (large losses, negative equity, and high leverage with ongoing cash burn). Technicals provide some support via a strong move above major moving averages, but overbought signals and slightly negative MACD add near-term risk. Valuation remains unattractive/unclear due to negative earnings and no dividend.
Aquarius Surgical Technologies (ASTI) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 115.92K
- Dividend Yield
- ―
- Average Volume (3M)
- 37.59K
- Price to Earnings (P/E)
- -0.3
- Beta (1Y)
- -0.31
- Revenue Growth
- 8.66%
- EPS Growth
- -545.88%
- Country
- Canada
- Employees
- 3
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Devices
Aquarius Surgical Technologies Business Overview & Revenue Model
Company Description
Aquarius Surgical Technologies Inc., operating through its subsidiary Surgical Lasers Inc., specializes in the creation, sale, distribution, and promotion of advanced technological solutions tailored for surgical and other healthcare settings through...
Aquarius Surgical Technologies Financial Statement Overview
Summary
Financials are highly stressed despite a TTM revenue rebound (+20.3%): profitability remains extremely weak (net margin about -713%) with ongoing EBIT/EBITDA losses, negative equity (~-6.6M), and high debt relative to assets (debt ~7.1M vs assets ~1.9M). Cash flow is still negative (TTM FCF roughly -88k), implying reliance on external funding.
Income Statement
18Very NegativeBalance Sheet
8Very NegativeCash Flow
20Very Negative| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2023 | Mar 2022 | Jun 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 91.44K | 91.44K | 91.20K | 205.25K | 327.66K | 958.74K |
| Gross Profit | 40.16K | 33.48K | 47.31K | 132.85K | 130.30K | 378.25K |
| EBITDA | 655.51K | -241.88K | -832.81K | -456.62K | -611.35K | -1.18M |
| Net Income | -651.71K | -651.71K | -1.17M | -757.66K | -859.20K | -1.61M |
Balance Sheet | ||||||
| Total Assets | 1.91M | 1.91M | 1.95M | 574.44K | 894.98K | 1.66M |
| Cash, Cash Equivalents and Short-Term Investments | 44.51K | 44.51K | 7,559 | 107.38K | 158.19K | 105.19K |
| Total Debt | 6.94M | 6.94M | 6.47M | 4.04M | 3.24M | 2.02M |
| Total Liabilities | 8.34M | 8.34M | 7.72M | 5.18M | 4.11M | 2.35M |
| Stockholders Equity | -6.42M | -6.42M | -5.77M | -4.61M | -3.21M | -689.15K |
Cash Flow | ||||||
| Free Cash Flow | -116.36K | -116.36K | -383.29K | -256.92K | -117.38K | -1.07M |
| Operating Cash Flow | -116.36K | -116.36K | -383.29K | -252.56K | -112.16K | -951.17K |
| Investing Cash Flow | 0 | 0 | -1.80M | -4,358 | -5,221 | -86.99K |
| Financing Cash Flow | 153.31K | 153.31K | 2.08M | 242.29K | 129.59K | 1.02M |
Aquarius Surgical Technologies Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:ASTI, the sentiment is Positive. The current price of 0.01 is above the 20-day moving average (MA) of 0.01, above the 50-day MA of 0.01, and above the 200-day MA of 0.01, indicating a bullish trend. The MACD of 0.00 indicates Negative momentum. The RSI at 81.36 is Negative, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:ASTI.
Aquarius Surgical Technologies Peers Comparison
Overall Rating
TSE:PRN50Neutral
TSE:ASG47Neutral
TSE:VPT46Neutral- TSE:ASTI45Neutral
TSE:PINK38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| TSE:PRN | 50Neutral | CAD 335.37M | -6.77 | -62.45% | ― | 59.60% | 32.53% |
| TSE:ASG | 47Neutral | CAD 8.98M | -5.36 | -34.32% | ― | -5.42% | -5.37% |
| TSE:VPT | 46Neutral | CAD 15.43M | -6.13 | 56.40% | ― | 89.06% | 37.62% |
| TSE:ASTI | 45Neutral | CAD 413.99K | -0.27 | 23.95% | ― | 8.66% | -545.88% |
| TSE:PINK | 38Underperform | CAD 27.62M | -1.41 | -303.05% | ― | 35.27% | 58.34% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:ASTI | Aquarius Surgical Technologies | 0.01 | 0.00 | 0.00% | |
| TSE:ASG | Aurora Spine | 0.12 | -0.17 | -58.93% | |
| TSE:PINK | Perimeter Medical Imaging Ai Inc | 0.18 | -0.05 | -23.40% | |
| TSE:PRN | Profound Medical | 9.18 | 0.91 | 11.00% | |
| TSE:VPT | VentriPoint Diagnostics | 0.08 | -0.02 | -20.00% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 21, 2026